Discrepancy in Metabolic Dysfunction–Associated Steatotic Liver Disease Prevalence in a Large Northern California Cohort
Background and Aims: The estimated prevalence of metabolic dysfunction–associated steatotic liver disease (MASLD) in US adults is 31.3%. However, little is known about MASLD diagnosis rates in clinical practice. We used data from electronic health records and assessed the annual MASLD prevalence. Me...
Saved in:
| Main Authors: | Luis A. Rodriguez, Lue-Yen S. Tucker, Varun Saxena, Theodore R. Levin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Gastro Hep Advances |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772572325000172 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Consensus Statement on Metabolic Dysfunction‐Associated Steatotic Liver Disease in Children and Adolescents From the Joint TASL‐TSPGHAN Expert Committee
by: Yu‐Cheng Lin, et al.
Published: (2025-06-01) -
Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Pathogenic Mechanisms and Therapeutic Implications
by: Farah Abdelhameed, et al.
Published: (2025-03-01) -
<i>Lactobacillus</i> sp. for the Attenuation of Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice
by: Titilayo Olotu, et al.
Published: (2024-12-01) -
Development of SOCS1 mimetics as novel approach to harmonize inflammation, oxidative stress, and fibrogenesis in metabolic dysfunction-associated steatotic liver disease
by: Susana Bernal, et al.
Published: (2025-07-01) -
Dietary Interventions and Physical Activity as Crucial Factors in the Prevention and Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Paweł Rajewski, et al.
Published: (2025-01-01)